Introduction {#sec1}
============

Novel transition-metal-catalyzed carboxylation reactions with CO~2~ in organic synthesis have been extensively applied for large-scale industrial applications^[@ref1],[@ref2]^ as well as for accessing isotopically labeled carboxylic acids from \[^13^C\]CO~2~ or \[^14^C\]CO~2~.^[@ref3],[@ref4]^ \[^11^C\]CO~2~ is a cyclotron-generated building block produced by the proton bombardment of nitrogen gas (^14^N(p,α)^11^C; *t*~1/2~ = 20.3 min) in the presence of trace oxygen. Recent years have seen a renaissance in \[^11^C\]CO~2~ fixation strategies for the synthesis of ^11^C=O-labeled compounds and radiopharmaceuticals and have been applied to in vivo medical imaging with positron emission tomography (PET).^[@ref5]−[@ref8]^ Organic bases capable of efficiently trapping \[^11^C\]CO~2~, such as 1,8-diazabicyclo\[5.4.0\]undec-7-ene (DBU) and 2-*tert*-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine (BEMP), enable mild (room temperature) one-pot radiosyntheses of \[^11^C\]carbamates, \[^11^C\]ureas, and \[^11^C\]oxazolidones.^[@ref6],[@ref7],[@ref9]−[@ref11]^ The ^11^C-carbamate \[^11^C\]CURB^[@ref12],[@ref13]^ and ^11^C-oxazolidone \[^11^C\]SL25.1188^[@ref14],[@ref15]^ were developed at our laboratories for imaging fatty acid amide hydrolase and monoamine oxidase B, respectively, and have been translated for human PET studies. In contrast, the synthesis of ^11^C-carboxylic acids via \[^11^C\]CO~2~ fixation has proven to be more challenging. Traditional methods to produce carboxylic acids from \[^11^C\]CO~2~ using air- and moisture-sensitive Grignard, organolithium, or silanamine reagents are limited by poor functional group tolerance and the need to continuously exclude atmospheric CO~2~.^[@ref6]^ Metal-catalyzed direct carboxylation of aryl halides and pseudo-halides employing CO~2~ in drug discovery has recently been reviewed in the context of identifying opportunities for the radiolabeling of \[^11^C\]carboxylic acid based drugs via \[^11^C\]CO~2~ fixation.^[@ref2]^ Only a handful of aromatic ^11^C-carboxylic acids have been radiolabeled and translated for preclinical PET imaging,^[@ref16]−[@ref21]^ and new ^11^C-carboxylation approaches are avidly sought. For example, retinoid X receptor (RXR) agonists and partial agonists are a class of drugs for oncology and neurodegenerative diseases that generally contain an aromatic carboxylic acid moiety.^[@ref22]^ In particular, the RXR agonist bexarotene (Targretin) is an FDA-approved drug for the treatment of cutaneous T-cell lymphoma (CTCL)^[@ref23]^ and has more recently been investigated for the treatment of Alzheimer's disease.^[@ref24]^[Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} illustrates three examples of ^11^C-carboxyl-based imaging agents that were synthesized via \[^11^C\]CO~2~ fixation methods for neuroimaging of RXRs: \[^11^C\]bexarotene (**A**; \[^11^C\]**13b**),^[@ref16],[@ref17]^ \[^11^C\]6-\[ethyl-(4-isobutoxy-3-isopropylphenyl)amino\]pyridine-3-carboxylic acid (**B**),^[@ref18]^ and \[^11^C\]1-\[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-amino\]benzotriazole-5-carboxylic acid (**C**).^[@ref20]^

![Examples of RXR agonists and partial agonists radiolabeled using \[^11^C\]CO~2~ fixation: \[^11^C\]bexarotene (\[^11^C\]**13b**; **A**), \[^11^C\]6-\[ethyl-(4-isobutoxy-3-isopropylphenyl)amino\]pyridine-3-carboxylic acid (**B**), and \[^11^C\]1-\[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-amino\]benzotriazole-5-carboxylic acid (**C**).](ao0c00524_0009){#fig1}

Riss et al. reported a mild one-pot procedure for the conversion of boronic esters to \[^11^C\]carboxylic acids mediated by a copper(I) source and \[^11^C\]CO~2~ as the radiochemical feedstock ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref25]^ The strategy has advantages for the preparation of \[^11^C\]carboxylic acids, including a broad functional group tolerance and the ability to generate aryl, vinyl, and alkynyl ^11^C-carboxylic acids in high RCYs (\>70%). This strategy also offers a novel route to ^11^C-labeled esters and amides.^[@ref25]^ The procedure was adapted by our group to synthesize the prototypical RXR agonist, \[^11^C\]bexarotene ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A), and was translated for preclinical PET imaging in nonhuman primates.^[@ref16],[@ref17]^ Despite these initial advances, Kakuta et al. found that aryl boronic esters afforded low yields (\<1%) for the ^11^C-radiolabeling of the common aromatic carboxylic moiety in next-generation RXR agonists and partial agonists ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B,C), and the authors reverted to traditional \[^11^C\]CO~2~ fixation reactions via organolithiation procedures to prepare these labeled compounds in low yields.^[@ref18],[@ref20]^ More recently, Rafique et al. also reported that \[^11^C\]CO~2~ fixation via Grignard reagents in a three-step route to ^11^C-amides was preferred over the use of boronic esters.^[@ref26]^ Thus, we were motivated to explore alternative ^11^C-carboxylation strategies that are transferrable for both CO~2~ at 1 atm pressure as well as sub-stoichiometric quantities of \[^11^C\]CO~2~. We hypothesized that organostannanes could also be suitable precursors to carry out copper(I)-catalyzed ^11^C-carboxylation reactions. Organostannanes offer several advantages including their general stability to air and moisture, established synthetic methods, and commercial availability with widespread use as precursors in PET radiochemistry. Organotin compounds have also found utility alongside boronic esters^[@ref27]^ in Pd(0)-mediated cross-coupling reactions with \[^11^C\]CH~3~I in the Stille and Suzuki reactions, respectively,^[@ref28]^ as well as in Cu(II)-mediated ^11^C-cyanation reactions.^[@ref29],[@ref30]^ The activation of organostannanes (RSnBu~3~; R = aryl, vinyl) using Cu(I) has also been utilized in Stille-type cross-coupling reactions with vinyl and aryl iodides,^[@ref31]−[@ref33]^ where formation of an organocuprate (RCu(I)) is considered as a key step in these reactions.^[@ref34],[@ref35]^ The knowledge that organocuprates readily undergo CO~2~ insertion, also a key step in the Cu-catalyzed carboxylation of boronic acids^[@ref36]^ and esters,^[@ref37],[@ref38]^ supports our hypothesis that organostannanes would be suitable for this transformation.

![Radiosynthesis of (Hetero)aromatic Carboxylic Acids from \[^11^C\]CO~2~](ao0c00524_0008){#sch1}

In the present study, we report the unprecedented Cu(I)-mediated carboxylation of (hetero)arylstannanes ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). After first evaluating the reaction using CO~2~ at atmospheric pressure, the radiochemical yield for \[^11^C\]benzoic acid (\[^11^C\]**1b**) formation from tributylphenylstannane (**1a**), using \[^11^C\]CO~2~,was next optimized. This was followed by an assessment of the substrate scope with the aim of evaluating the sensitivity of the reaction to electron-withdrawing and -donating substituents as well as oxygen-, sulfur-, and nitrogen-containing heteroarenes. Finally, the methodology was applied to the labeling of \[^11^C\]bexarotene.

Results and Discussion {#sec2}
======================

The feasibility of the Cu(I)-mediated carboxylation of (hetero)arylstannanes was first investigated using stable CO~2~, and the reaction conditions described in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Our general procedure was adapted from the work of Takaya et al.^[@ref37]^ for the carboxylation of aryl boronic esters: a DMF solution (2.5 mL) containing organostannane (0.08 M, 0.2 mmol, 1.0 equiv.), *N*,*N*,*N*′,*N*′-tetramethylethylenediamine (TMEDA; 0.67 M, 1.7 mmol, 8.4 equiv.), and copper(I) thiophene-2-carboxylate (CuTC; 3.8 mM, 9.4 μmol, 0.05 equiv.) was sealed under an atmosphere of CO~2~ and heated at 90 °C for 17 h. Isolated yields of 58 and 33% were obtained for the formation of carboxylic acids **1b** and **4b**, respectively. Both carboxylic acids were isolated with reasonably high purity without the need for chromatographic separation. Analytical HPLC analyses of the reaction mixtures revealed lower conversions for **11b** (8%) and **13b** (6%). The relatively high yields of **1b** and **4b** suggest the active copper(I) species (present in ca. 5 mol % relative to organostannane) to be catalytic in these reactions but stoichiometric in the latter two instances. Ohishi et al.^[@ref38]^ and Nayal et al.^[@ref36]^ have both reported that the addition of an exogenous alkoxide is required for the carboxylation of boronic acids and esters to be catalytic in Cu(I) species. We did not pursue the effect of alkoxide addition as Riss et al. demonstrated that \[^11^C\]CO~2~ was rendered unreactive in the copper-mediated carboxylation of boronic esters upon addition of potassium *tert*-butoxide.^[@ref25]^

###### Carboxylation of Arylstannanes Using 1 atm CO~2~[a](#t1fn1){ref-type="table-fn"}

![](ao0c00524_0004){#gr6}

![](ao0c00524_0001){#gr7}

Reactions were carried out using the following conditions: DMF (2.5 mL); \[TMEDA\] = 0.67 M; \[ArSnBu~3~\] = 0.08 M; \[CuTC\] = 3.8 mM; 90 °C; 17 h.

Yields determined by HPLC analyses of the crude reaction mixture relative to reference standards of the respective products.

Characterization by ^1^H, ^13^C{1H}, and ^19^F{1H} NMR spectroscopy (when applicable).

While **11b** and **13b** could not be isolated, their presence was confirmed by HPLC analyses of the crude reaction mixture upon addition of a reference sample (see [Figures S3 and S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00524/suppl_file/ao0c00524_si_001.pdf)).

In order to successfully translate a carboxylation method for use with \[^11^C\]CO~2~, the reaction must be compatible with the conditions that allow for a sub-stoichiometric quantity of \[^11^C\]CO~2~ to be delivered into solution and reasonably retained at elevated temperatures (80--120 °C) for the duration of the reaction. This entails the use of a high-boiling-point polar aprotic amide solvent, a Cu(I) source, an amine that serves as both a base and ligand for the copper species, and the organostannane precursor. Thus, we first carried out screening of the reaction conditions to maximize the RCY (non-isolated and decay-corrected) of \[^11^C\]benzoic acid (\[^11^C\]**1b**; see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) using those adapted from our previous ^11^C-carboxylation method for \[^11^C\]bexarotene radiosynthesis as a starting point (substrate: **1a** (0.1 M); solvent: *N*-methyl-2-pyrrolidone (NMP; 600 μL); temperature: 100 °C; time: 5 min; base/ligand: TMEDA (1.2 M); copper source: CuTC (8.7 mM)).^[@ref16]^ RCYs were determined from radio-HPLC analyses of the product mixture, taking into account losses of volatile \[^11^C\]CO~2~ from the solution (i.e., during the transfer of activity into solution at room temperature, following heating, and upon acidifying the reaction mixture) using a sodium hydroxide coated silica (Ascarite II, 20--30 mesh) trap. Thus, the (decay-corrected) trapping efficiency (TE) was also quantified as the activity retained in the final product vial.

###### Reaction Screening and Optimization[a](#t2fn1){ref-type="table-fn"}

![](ao0c00524_0003){#gr8}

  entry                                                                    precursor loading (μmol)   solvent   temperature (°C)   TE[b](#t2fn2){ref-type="table-fn"} (%)   RCY[c](#t2fn3){ref-type="table-fn"} (%)
  ------------------------------------------------------------------------ -------------------------- --------- ------------------ ---------------------------------------- -----------------------------------------
  1                                                                        60                         NMP       100                50                                       50
  2                                                                        60                         DMA       100                45                                       35
  3[d](#t2fn4){ref-type="table-fn"}                                        60                         DMF       100                69 ± 3                                   67 ± 5
  4[e](#t2fn5){ref-type="table-fn"}                                        60                         DMF       110                61 ± 12                                  58 ± 12
  5                                                                        60                         DMF       120                50                                       47
  6                                                                        60                         NMP       80                 50                                       41
  7[f](#t2fn6){ref-type="table-fn"}                                        60                         NMP       100                53                                       49
  8[g](#t2fn7){ref-type="table-fn"}                                        60                         DMF       100                97                                       2
  9[h](#t2fn8){ref-type="table-fn"}                                        60                         DMF       110                6                                        5
  10[i](#t2fn9){ref-type="table-fn"}                                       60                         DMF       110                42                                       31
  11[j](#t2fn10){ref-type="table-fn"}                                      60                         DMF       100                6                                        0.01
  12                                                                       30                         DMF       100                48                                       45
  13                                                                       15                         DMF       100                48                                       40
  14[d](#t2fn4){ref-type="table-fn"}^,^[k](#t2fn11){ref-type="table-fn"}   30                         DMF       110                35 ± 3                                   33 ± 4

Unless otherwise stated, reactions were carried out using the following standard conditions and are *n* = 1: solvent (600 μL); **1a** (19.6 μL, 60 μmol, 0.1 M); CuTC (5.3 μmol, 8.7 mM); TMEDA (0.8 mmol, 1.3 M); temperature: 100 °C; time: 5 min.

TE (trapping efficiency): percentage of total activity that remains in solution after acidifying the reaction mixture.

RCY (radiochemical yield): percentage of total activity converted to \[^11^C\]**1b**.

*n* = 3.

*n* = 2.

TMEDA (240 μL, 1.6 mmol, 2.6 M).

DMEDA as the base.

CuTC (0.1 mg, 0.52 μmol, 0.87 mM).

CuTC (5.4 mg, 28.6 μmol, 47.0 mM).

CuI as the Cu(I) source.

Half-quantity of all reagents: DMF (300 μL); **1a** (9.8 μL, 30 μmol); CuTC (2.7 μmol); TMEDA (0.4 mmol).

Examination of three polar aprotic amide solvents ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 1--3), NMP, *N*,*N*-dimethylformamide (DMF), and *N*,*N*-dimethylacetamide (DMA), revealed the RCY to decrease sequentially in the following order: DMF (67 ± 5%) \> NMP (50%) \> DMA (35%). Variation of the reaction temperature between 80 and 120 °C suggests an optimum value of 100 °C ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 1, 3--6); increasing the temperature leads to a decrease in TE, while decreasing to 80 °C increases the percentage of activity that remains unreacted. Doubling the concentration of TMEDA had little effect on the RCY and TE. Exchanging the base for *N*,*N*′-dimethylethylenediamine (DMEDA) while dramatically improving the TE of the solution rendered the \[^11^C\]CO~2~ unreactive for the desired transformation ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 8). Riss et al. reported that a ca. 7-fold decrease in the quantity of the Cu(I) source (along with a reduction in fluoride source quantity) led to an increase in RCY for the carboxylation of boronic esters.^[@ref25]^ A 10-fold decrease or 5-fold increase in CuTC concentration in our reaction, however, resulted in a detrimental effect on the RCY ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 9 and 10). Minimizing the quantity of CuTC is also desirable given the potential for complications that may arise from the formation of thiophene-2-carboxylic acid, which is generated after acidifying the reaction mixture, during the isolation and/or further derivatization of the desired product. Only trace amounts of \[^11^C\]**1b** were observed when CuI was used as the copper(I) source ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 11). This is expected given the dramatic effect of iodide for 2-thiophene carboxylate (TC) exchange for the activation of arylstannanes^[@ref31],[@ref35]^ and is attributed to the exergonic differences of the initial transmetalation step (see [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Finally, we systematically decreased the concentration of **1a** in order to evaluate the quantity of the precursor that is required to carry out the transformation as it would be advantageous to decrease the required amount of precursor so as to simplify purification. Relative to the optimized reaction conditions (\[**1a**\] = 0.1 M, corresponding to ca. 60 μmol or 22 mg), decreasing the precursor loading by 50 and 75% ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 12--13) led to decreases in the resulting RCYs (i.e., 67 ± 5, 45, and 40%, respectively). While we tested the substrate scope (vide infra) using our optimized conditions, the results in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} suggest that this reaction can tolerate a decrease in precursor loading. Attempts to decrease the precursor quantity by halving the amount of all reagents used once again led to a reduction in RCY (33 ± 4%, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 14), concurrent with a decrease in the TE of the solution. Systematic variation of the reaction parameters led to the following optimized conditions: temperature: 100 °C; time: 5 min; solvent: DMF (600 μL); \[**1a**\] = 0.1 M; \[CuTC\] = 8.7 mM; \[TMEDA\] = 1.3 M. A proof-of-concept reaction was carried out using the synthesis and isolation of \[^11^C\]**1b** as a representative ^11^C-labeled compound. Carbon-11-labeled **1b** was isolated in a decay-corrected RCY of 45% relative to starting \[^11^C\]CO~2~, with molar activity *A*~m~ = 9.3 GBq/μmol (250 mCi/μmol) and radiochemical purity \>99%, with an overall synthesis and purification time of 29 min.

We next investigated the substrate scope of the reaction using the optimized conditions and tributyltin-substituted by *para*-substituted benzene derivatives (ArSnBu~3~; see [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}), including those bearing electron-donating (*p*Me (**2a**), *p*MeO (**3a**)) and -withdrawing (*p*CF~3~ (**4a**), *p*Cl (**5a**)) groups. The scope was then extended further to include *N*-heteroarenes (**8a**--**11a**) as well as tributyltin substituted by the electron-rich heteroarenes furan (**6a**) and thienyl (**7a**). A representative alkyne, trimethyl(phenylethynyl)tin (**12a**), was also investigated. The carboxylation of **1a**--**5a** afforded moderate radiochemical yields (ca. 30--70%), with the exception of *p*Cl-substituted **5a**, which gave a lower yield. As the highest yield was obtained with the parent structure **1a**, we postulate that the RCY is similarly impacted by the presence of electron-donating (*p*Me, *p*MeO) or -withdrawing (*p*Cl, *p*CF~3~) groups. The reaction also facilitates the carboxylation of *N*-heteroarenes, with the formation of ^11^C-carboxylic acids bearing 3-pyridyl (\[^11^C\]**8b**) and 2-pyrazyl (\[^11^C\]**11b**) substituents being successfully generated with RCYs between 31 and 34%. On the other hand, the RCY is lower (4--6%) when carboxylation is carried out at both the 2- and 5-positions of a pyrimidyl ring (forming \[^11^C\]**9b** and \[^11^C\]**10b**, respectively). The yields appear to be most hindered with the transfer of electron-rich heteroarenes as the 2-furyl (**6a**)- and 2-thienyl (**7a**)-substituted tributyltin compounds afforded RCYs \<3% in both instances. Alkynyl-substituted trimethyltin compound **12a** did not yield the corresponding carboxylic acid \[^11^C\]**12b**. Radio-HPLC analysis of the crude reaction mixtures (following protonation) revealed that a relatively pure reaction had occurred in all cases; the only ^11^C-labeled impurity was attributed to \[^11^C\]CO~2~ and was common throughout all of the reactions.

![Substrate Scope of the ^11^C-Carboxylation Reaction. Non-isolated and Decay-Corrected RCYs Are in Parentheses and Are *n* = 2 Unless Otherwise Stated](ao0c00524_0007){#sch2}

This new ^11^C-carboxylation method was successfully applied to the fully automated radiosynthesis and purification of \[^11^C\]bexarotene (\[^11^C\]**13b**; *n* = 3) using the TracerMaker (Scansys Laboratorieteknik, Denmark) synthesis module ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). A decay-corrected RCY of 32 ± 5% was obtained relative to starting \[^11^C\]CO~2~, with molar activity *A*~m~ = 38 ± 23 GBq/μmol (1.0 ± 0.6 Ci/μmol) and radiochemical purities \>95% in all instances, from an overall synthesis and purification time of 41 ± 4 min. Isolated formulations (10% ethanol/90% saline v/v) contained up to 5.74 GBq (155 mCi) radioactivity and molar activities of up to *A*~m~ = 63 GBq/μmol (1.7 Ci/μmol).^[@ref39]^ These values are comparable to the decay-corrected RCY of 45% previously reported for \[^11^C\]**13b**^[@ref16]^ using the corresponding boronic ester precursor.

![Radiosynthesis of \[^11^C\]Bexarotene](ao0c00524_0006){#sch3}

We propose the reaction mechanism illustrated in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}, wherein each step is supported by a literature precedent. The (hetero)arene (Ar) is first transferred from tributyltin to copper in the initial transmetalation step, generating the corresponding organocuprate (L~1~CuAr) along with Bu~3~SnTC.^[@ref34],[@ref35]^ Experimental and theoretical studies have indicated that this process is reversible and close to ergoneutral.^[@ref31],[@ref35]^ The organocuprate then readily undergoes CO~2~-insertion to form the carboxylate complex L~1~CuOOCAr.^[@ref37],[@ref38]^ The large excess of arylstannane in solution then promotes a second ligand exchange process that simultaneously regenerates the organocuprate and forms the corresponding tributyltin carboxylate Bu~3~SnOOCAr, the latter of which is protonated to the carboxylic acid (ArCOOH) following acidic workup.^[@ref40]^ TMEDA likely serves as the ligand (L~1~) for the active Cu(I) species in solution.^[@ref25]^ As it is not mandatory for the reaction to be catalytic in the radiochemical experiments given the sub-stoichiometric quantities of \[^11^C\]CO~2~ being used, the mechanism in these cases may be viewed simply as a two-step transmetalation-insertion process. We envision that this methodology can be readily extended to reactions with ^13^CO~2~ and ^14^CO~2~.

![Proposed Mechanism of the Carboxylation Reaction](ao0c00524_0005){#sch4}

In conclusion, we have developed a novel copper-mediated carboxylation methodology for the preparation of (hetero)aryl carboxylic acids from organostannanes using a stoichiometric quantity of CO~2~ under atmospheric pressure as well as sub-stoichiometric quantities of \[^11^C\]CO~2~. The successful radiosynthesis, purification, and formulation of \[^11^C\]bexarotene, using a fully automated commercial synthesis module, suggest that this methodology could be applied in radiopharmaceutical production.

Methods {#sec3}
=======

General Methods and Instrumentation {#sec3.1}
-----------------------------------

^1^H and ^13^C{^1^H} NMR spectra were recorded at 400.22 (^1^H) and 100.64 MHz (^13^C{^1^H}) using a Bruker AV400 spectrometer and were referenced to the residual solvent proton and ^13^C signals, respectively. ^19^F{^1^H} NMR spectra were recorded at 376.58 MHz on a Bruker AV400 spectrometer and were referenced to an internal standard of 1,2-difluorobenzene (−140.53 ppm).^[@ref30]^ High-resolution mass spectra and exact masses were determined on a Waters GCT Premier mass spectrometer using electron ionization, an Agilent 6538 Q-TOF mass spectrometer using electrospray ionization, or a JEOL AccuTOF model JMS-T1000LC mass spectrometer using DART ionization. Melting points were measured on a Mel-Temp Melting Point Apparatus (Barnstead International). HPLC analyses of reaction mixtures were carried out using a Phenomenex (Prodigy C18, 250 × 4.6 mm, 10 μm) analytical HPLC column coupled to a high-pressure isocratic pump (Shimadzu LC-20AT) and a variable-wavelength UV detector (Shimadzu SPD-20A; λ = 254 nm). Data were recorded and analyzed using PowerChrom chromatography software. Column chromatography was carried out using silica gel 40--60 Å (Oakwood Chemical) as the stationary phase.

Materials {#sec3.2}
---------

Commercially available organostannanes (**1a**, **5a**--**12a**) were used as received from Sigma-Aldrich and have ≥95% purity in all instances. Reference standards of the carboxylic acids **1b**--**13b** were used as received from Sigma-Aldrich. Samples of TMEDA used for the synthesis of \[^11^C\]**13b** were stored under 4 Å molecular sieves, while CuTC (Sigma-Aldrich), CuI (Oakwood Chemical), LiCl (Oakwood Chemical), and Pd(PPh~3~)~4~ (Sigma-Aldrich) were handled in an argon-purged glove-bag. All other chemicals were obtained from Sigma-Aldrich, Oakwood Chemical, ACP Chemicals, Caledon, and Fisher Scientific and used as received without further purification.

Tributyl(*p*-tolyl)stannane (**2a**), tributyl(4-methoxyphenyl)stannane (**3a**), and tributyl(4-trifluoromethylphenyl)stannane (**4a**) were synthesized according to adapted literature procedures^[@ref41],[@ref42]^ and exhibited ^1^H, ^13^C{^1^H}, ^19^F{^1^H} NMR (for **4a**), and ESI-MS data that agree with those previously reported for the compounds.^[@ref43],[@ref44]^ 2,5-Dichloro-2,5-dimethylhexane (**S1**),^[@ref45],[@ref46]^ 1,1,4,4,6-pentamethyl-1,2,3,4-tetrahydronaphthalene (**S2**),^[@ref47],[@ref48]^ 4-iodophenyl-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-methanone (**S3**),^[@ref47]^ and 6-(1-(4-iodophenyl)vinyl)-1,1,4,4,7-pentamethyl-1,2,3,4-tetrahydronaphthalene (**S4**)^[@ref16],[@ref49]^ were prepared according to previously published procedures and exhibited NMR spectral data that agree with those previously published for the compounds. Additional spectral data for **S3**: ^13^C{^1^H} NMR (CDCl~3~): 197.7, 148.0, 141.9, 137.61, 137.59, 134.9, 134.2, 131.6, 129.3, 127.9, 100.8, 34.93, 34.88, 34.3, 33.9, 31.7, 31.6, 19.9.

Tributyl(4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)phenyl)stannane (**13a**) {#sec3.3}
------------------------------------------------------------------------------------------------------

The title compound was prepared in 19% overall yield according to a five-step procedure starting from 2,5-dimethyl-2,5-hexanediol (with intermediate compounds **S1**--**S4**; see [Scheme S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00524/suppl_file/ao0c00524_si_001.pdf)). In the final step, **13a** was prepared from **S4** using procedures adapted from those of Ritter and co-workers.^[@ref50]^ An oven-dried 25 mL Schlenk tube was fitted with a stir-bar and cooled under an atmosphere of argon before the addition of **S4** (0.50 g, 1.2 mmol) and anhydrous dioxane (ca. 10 mL). To the resulting mixture were added Pd(PPh~3~)~4~ (0.067 g, 0.058 mmol), LiCl (0.246 g, 5.81 mmol), and bis(tributyltin) (1.2 mL, 2.3 mmol) under a positive pressure of argon. The Schlenk tube was sealed and heated to 95 °C for ca. 20 h before being allowed to cool to room temperature. The resulting black solution was concentrated using a rotary evaporator. Purification of the crude residue by column chromatography on silica gel (eluent: hexanes/Et~3~N 99:1 (v/v)) afforded **13a** as a colorless oil (0.422 g, 0.712 mmol, 61%, *R*~f~ = 0.36 in hexanes/Et~3~N 99:1 (v/v)). **13a** was identified on the basis of its ^1^H, ^13^C{^1^H} NMR, ESI-MS, and HRMS data: ^1^H NMR (CDCl~3~): δ 7.38 (d, *J* = 7.9 Hz, *J*~HSn~ = 37.9 Hz, 2 H), 7.23 (d, *J* = 7.9 Hz, 2 H), 7.13 (s, 1 H), 7.07 (s, 1 H), 5.74 (d, *J* = 1.5 Hz, 1 H), 5.18 (d, *J* = 1.5 Hz, 1 H), 1.98 (s, 3 H), 1.70 (s, 4 H), 1.53 (m, 6 H), 1.33 (sextet, *J* = 7.5 Hz, 6 H), 1.30 (s, 6 H), 1.27 (s, 6 H), 1.04 (m, *J*~HSn~ = 50.4 Hz, 6 H), 0.88 (t, *J* = 7.3 Hz, 9 H). ^13^C{^1^H} NMR (CDCl~3~): δ 149.9, 143.8, 142.0, 141.3 (*J*~CSn~ = 390.7, 370.3 Hz), 140.4 (*J*~CSn~ = 10.3 Hz), 138.8, 136.4 (*J*~CSn~ = 31.1 Hz), 132.8, 128.1, 127.8, 125.9 (*J*~CSn~ = 41.2 Hz), 114.3, 35.28, 35.26, 34.0, 33.9, 31.93, 31.91, 29.1 (*J*~CSn~ = 19.9 Hz), 27.4 (*J*~CSn~ = 54.9 Hz), 19.9, 13.7, 9.6 (*J*~CSn~ = 339.5, 324.2 Hz). EI-MS, *m*/*z* (relative intensity; Sn-containing isotopologic clusters are represented by the ^120^Sn isotopolog and are indicated with asterisks): 593.3\* (1, M^+^), 537.2\* (100, (M--C~4~H~8~)^+^), 481.2\* (81, (M--2C~4~H~8~)^+^), 425.1\* (85, (M--3C~4~H~8~)^+^), 367.0\* (12, (M--C~17~H~22~)^+^), 289.2 (12, C~22~H~25~^+^), 103.1 (15, C~8~H~7~^+^). HRMS (EI-TOF+): \[M\]^+^ calcd for C~35~H~53~^120^Sn^+^ 593.3169; found 593.3185.

General Procedure for the Synthesis of Carboxylic Acids {#sec3.4}
-------------------------------------------------------

Carboxylic acids **1b**, **4b**, **11b**, and **13b** were prepared according to procedures adapted from those of Takaya et al. for the copper(I)-catalyzed carboxylation of arylboronic esters.^[@ref37]^ An oven-dried 10 mL v-vial, charged with a spin vane and sealed with a hole cap and septum, was allowed to cool in an atmosphere of argon. To the vial was added CuTC (1.8 mg, 9.4 μmol) followed by the addition of DMF (ca. 2.50 mL), TMEDA (ca. 0.25 mL), and the corresponding arylstannane (0.20 mmol) using microliter syringes. To the resulting pale-blue solution was introduced gaseous CO~2~, which was produced from dry ice (in a sealed vessel) and transferred to the solution using a hypodermic needle. Gaseous CO~2~ was bubbled through the reaction solution for ca. 25 min before the v-vial was sealed using a new hole cap and (unpunctured) septum. The sealed vial was then heated at 90 °C for 17 h before being allowed to cool to room temperature. An aliquot (150 μL) of the resulting solution was acidified with ca. 0.67 M aqueous formic acid (1.50 mL) and analyzed by HPLC (see [Figures S1--S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00524/suppl_file/ao0c00524_si_001.pdf)). The bulk reaction mixture was transferred to an Erlenmeyer flask and quenched with ca. 0.67 M aqueous HCl solution (ca. 24 mL). The mixture was then transferred to a separatory funnel and extracted with Et~2~O (3 × 15 mL). The combined organic extracts were dried using MgSO~4~, filtered, and solvent-removed using a rotary evaporator. Pentane (ca. 1 mL) was added to the resulting crude oil to induce the precipitation of yellow crystals. The crystals were washed with additional portions of cold pentane (5 × 0.5 mL) before the solid was dried under vacuum (ca. 40 mmHg) for 1--2 h.

Benzoic Acid (**1b**) {#sec3.5}
---------------------

The title compound was prepared using arylstannane **1a** (73.4 mg, 0.200 mmol). **1b** was isolated as yellow crystals (14.2 mg, 0.116 mmol, 58%, mp 118--120 °C (lit. 122 °C)^[@ref51]^) and was identified on the basis of its ^1^H, ^13^C{^1^H} NMR, and HRMS data, which agree with those previously reported for the compound:^[@ref52],[@ref53]1^H NMR (CDCl~3~): δ 8.13 (d, *J* = 8.5 Hz, 2 H), 7.62 (t, *J* = 7.2 Hz, 1 H), 7.49 (t, *J* = 7.7 Hz, 2 H). ^13^C{^1^H} NMR (CDCl~3~): δ 171.7, 133.7, 130.2, 129.2, 128.5. HRMS (DART): \[M + H\]^+^ calcd for C~7~H~7~O~2~^+^ 123.0441; found 123.0446.

4-(Trifluoromethyl)benzoic Acid (**4b**) {#sec3.6}
----------------------------------------

The title compound was prepared using arylstannane **4a** (90.8 mg, 0.200 mmol). **4b** was isolated as pale-yellow crystals (13.1 mg, 0.0689 mmol, 33%) and was identified on the basis of its ^1^H, ^13^C{^1^H}, ^19^F{^1^H} NMR, and HRMS data, which agree with those previously reported for the compound:^[@ref52],[@ref54],[@ref55]1^H NMR (DMSO-*d*~6~): δ 13.4 (br, 1 H), 8.13 (d, *J* = 8.2 Hz, 2 H), 7.87 (d, *J* = 8.2 Hz, 2 H). ^13^C{^1^H} NMR (DMSO-*d*~6~): δ 166.2, 134.6, 132.5 (q, *J*~CF~ = 32.2 Hz), 130.1, 125.6 (q, *J*~CF~ = 3.7 Hz), 123.8 (q, *J*~CF~ = 271.5 Hz). ^19^F{^1^H} NMR (DMSO-*d*~6~): -62.9. ESI-MS, *m*/*z* (relative intensity): 189.02 (100, (M--H)^−^), 145.03 (17, (M--CHO~2~)^−^). HRMS (ESI): \[M--H\]^−^ calcd for C~8~H~4~F~3~O~2~^--^ 189.0169; found 189.0171. Heating a sample of **4b** in a melting point capillary tube led to sublimation at ca. 165 °C; a reference sample of **4b** also sublimed at 170--175 °C.

Radiochemistry: General Remarks, Methods, and Instrumentation {#sec3.7}
-------------------------------------------------------------

No carrier added \[^11^C\]CO~2~ was produced using a MC17 cyclotron (Scanditronix) by the ^14^N(p,α)^11^C reaction and a gaseous target of N~2~ (+0.5% O~2~). The time at which \[^11^C\]CO~2~ was delivered to the synthesis module is defined as the start-of-synthesis, while the end-of-synthesis is defined as the time at which the activity of the isolated product formulation was measured.

Synthesis and Characterization of \[^11^C\]**1b**--\[^11^C\]**12b** {#sec3.8}
-------------------------------------------------------------------

Reactions were carried out using 5 mL disposable centrifuge tubes (Kimble Glass Inc.) sealed with a hole cap and septum. Immediately prior to radiosynthesis, an oven-dried centrifuge tube was charged with the appropriate copper(I) salt in an argon-purged glove-bag followed by the sequential addition of solvent, base, and organostannane using microliter syringes. \[^11^C\]CO~2~ produced from the cyclotron was first transferred from the target to a molecular sieve trap at room temperature before being released (at 350 °C) and reconcentrated in a silica-gel trap cooled with liquid nitrogen. \[^11^C\]CO~2~ was then transferred to the reaction mixture by warming the trap to room temperature under a preset flow rate (ca. 10 mL/min) of gaseous He. \[^11^C\]CO~2~ was then transferred to the solution for 1 min and was followed by flushing the headspace with He (ca. 10 mL/min) for an additional minute. The reaction vessel was then sealed, and the solution was heated to the desired temperature for 5 min. Afterwards, the mixture was diluted with ca. 1 mL of water before being transferred to a septum-capped 20 mL glass vial (i.e., product vial). The solution was acidified with ca. 4 mL of aqueous 1 M formic acid solution and bubbled with nitrogen gas for an additional 2--3 min. The activity in the product vial was then quantified, and its radiochemical identity and purity were analyzed using radio-HPLC.

The vent-line of the reaction vessel was fitted with a sodium hydroxide coated silica (Ascarite II, 20--30 mesh) trap (denoted as AT1) to capture the activity lost during the transfer of \[^11^C\]CO~2~ into solution at room temperature. While the reaction vessel was sealed, AT1 was replaced with a second trap (AT2) to capture the activity that escapes the solution during heating and after the addition of ca. 1 mL of water. The vent-line of the product vial was also fitted with a third trap (AT3) to quantify the activity lost upon addition of the 1 M formic acid solution and bubbling the reaction mixture with nitrogen gas. All activity values were decay-corrected to the same point in time. The total activity for each reaction was estimated by adding the activities measured in the product vial and three traps (AT1--3). The decay-corrected radiochemical yield (RCY (%)) is defined as the amount of activity in the product vial multiplied by its radiochemical purity (as determined by radio-HPLC) and divided by the total activity. The decay-corrected trapping efficiency (TE (%)) is defined as one minus the ratio of activity in AT1--3 versus the total activity.

Procedure for the Synthesis and Isolation of \[^11^C\]**1b** {#sec3.9}
------------------------------------------------------------

\[^11^C\]CO~2~ was produced from the cyclotron and transferred, as previously described, to a reaction mixture consisting of DMF (600 μL), CuTC (0.7 mg, 3.7 μmol), TMEDA (120 μL, 0.800 mmol), and **1a** (19.6 μL, 60.1 μmol). The reaction vessel was then sealed and heated at 100 °C for 5 min. Subsequently, the reaction mixture was quenched/diluted with 1 M aqueous formic acid solution (ca. 4 mL), mixed, and transferred to a 5 mL HPLC loop before being injected to a semipreparative HPLC column (Phenomenex; Luna C18, 250 × 10 mm, 10 μm). The separation and isolation of \[^11^C\]**1b** were carried out using the Tracerlab FX2C module (General Electric) using a mobile phase consisting of acetonitrile/H~2~O/trifluoroacetic acid (TFA) (25:75:0.1; by volume) and a flow rate of 9 mL/min. The peak due to \[^11^C\]**1b** was then collected (retention time of ca. 9.5 min; see [Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00524/suppl_file/ao0c00524_si_001.pdf)) in a septum-capped 20 mL glass vial. An activity of 157 mCi was obtained at the end-of-synthesis from a total synthesis and purification time of ca. 29 min, corresponding to decay- and non-decay-corrected RCYs of 45 and 17%, respectively.

Procedure for the Synthesis and Isolation of \[^11^C\]**13b** {#sec3.10}
-------------------------------------------------------------

Immediately prior to radiosynthesis, an oven-dried 4 mL reaction vessel was charged with **13a** (35.6 mg, 60.0 μmol). The vessel was then transferred to an argon-purged glove-bag where DMF (600 μL), TMEDA (120 μL, 0.800 mmol), and CuTC (0.7 mg, 3.7 μmol) were added, and the vessel was sealed with a hole cap and septum. The automated synthesis and isolation of \[^11^C\]**13b** were performed on a TracerMaker synthesis module (Scansys Laboratorieteknik, Denmark; see flowcharts in [Figures S20 and S21](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00524/suppl_file/ao0c00524_si_001.pdf)). \[^11^C\]CO~2~ was produced from the cyclotron as previously described and transferred from the target to a HeySep D column (700 mg) cooled to −180 °C using liquid nitrogen. The HeySep D column was first gradually heated to −40 °C under helium flow (ca. 100 mL/min) to remove by-products that may have been produced during the ^14^N(p,α)^11^C reaction. \[^11^C\]CO~2~ was subsequently released by warming the trap to room temperature and transferred, under a preset flow rate (ca. 10 mL/min) of gaseous He, to the reaction vessel containing the solution mixture. The vessel was then sealed and heated at 100 °C for 5 min. Afterwards, the reaction mixture was diluted with ca. 2 mL of acetonitrile/H~2~O/TFA (80:20:0.1; by volume) and transferred to a 5 mL HPLC loop before being injected to a semipreparative HPLC column (Phenomenex; Gemini C18, 250 × 10 mm, 10 μm). The isolation of \[^11^C\]**13b** was carried out using a mobile phase consisting of acetonitrile/H~2~O/TFA (80:20:0.1; by volume) and a flow rate of 9 mL/min. The peak due to \[^11^C\]**13b** was then collected with a retention time of ca. 9.7 min (see [Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00524/suppl_file/ao0c00524_si_001.pdf)). After removal of the mobile phase, \[^11^C\]**13b** was then formulated in an ethanol/saline (10:90 v/v) mixture. The formulation at the end-of-synthesis contained 155 mCi of radioactivity from a synthesis and purification time of 37 min, corresponding to decay- and non-decay-corrected RCYs of 35 and 10%, respectively.

Analysis of Radiochemical Identity and Purity Using Radio-HPLC {#sec3.11}
--------------------------------------------------------------

Analysis of ^11^C-radiosynthesis reactions was carried out using a Phenomenex (Prodigy C18, 250 × 4.6 mm, 10 μm) analytical HPLC column coupled to a high-pressure isocratic pump (Shimadzu LC-20AT) and attached sequentially to a variable-wavelength UV detector (Shimadzu SPD-20A; λ = 254 nm) and radioactivity detector (Frisk-tech, Bicron; γ-ray). Data were recorded and analyzed using PowerChrom chromatography software. Seven different isocratic HPLC separation methods (denoted as methods A--G) were utilized over the course of this study: method A: Mobile phase: acetonitrile/H~2~O/TFA (25:75:0.1; by volume); flow rate: 2 mL/min. Method B: Mobile phase: acetonitrile/H~2~O/TFA (25:75:0.1; by volume); flow rate: 3 mL/min. Method C: Mobile phase: acetonitrile/H~2~O/TFA (40:60:0.1; by volume); flow rate: 2 mL/min. Method D: Mobile phase: acetonitrile/H~2~O/TFA (10:90:0.1; by volume); flow rate: 1 mL/min. Method E: Mobile phase: acetonitrile/H~2~O/TFA (10:90:0.1; by volume); flow rate: 2 mL/min. Method F: Mobile phase: acetonitrile/H~2~O/TFA (80:20:0.1; by volume); flow rate: 2 mL/min. Method G: Mobile phase: acetonitrile/0.1 M NH~4~CO~2~H (70:30; by volume); flow rate: 2 mL/min.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c00524](https://pubs.acs.org/doi/10.1021/acsomega.0c00524?goto=supporting-info).Analysis of reaction mixtures by HPLC for the synthesis of **1b**, **4b**, **11b**, and **13b**; HPLC chromatograms for the synthesis and isolation of \[^11^C\]**1b** and \[^11^C\]**13b** using semipreparative HPLC; analysis of radiochemical identity and purity for the synthesis of \[^11^C\]**1b**--\[^11^C\]**13b**; schematic flowcharts of the TracerMaker synthesis module; ^1^H, ^13^C{^1^H}, and ^19^F{^1^H} NMR spectra of synthesized compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00524/suppl_file/ao0c00524_si_001.pdf))

Supplementary Material
======================

###### 

ao0c00524_si_001.pdf

The authors declare no competing financial interest.

N.V. thanks National Institute on Ageing of the NIH (R01AG054473), the Azrieli Foundation, Canada Foundation for Innovation, Ontario Research Fund, and the Canada Research Chairs Program for support.
